Be The Match BioTherapies
Kelsey Merck is a Cell & Gene Therapy Operations Specialist at NMDP BioTherapies since July 2022, bringing a wealth of experience in the healthcare sector. Prior to this role, Kelsey worked as a Clinical Software Implementation Specialist at Title21 Health Solutions from September 2020 to June 2022. Kelsey has an extensive background at Memorial Sloan Kettering Cancer Center, where roles included Supervisor of the Cell Therapy Laboratory and Clinical Laboratory Technologist positions between October 2016 and September 2020. Earlier experience includes serving as a Quality Control Technologist at the National Cord Blood Program, New York Blood Center from November 2013 to October 2016. Kelsey holds a Master of Health Administration from Utica University (2017-2019) and a Bachelor of Science in Medical Laboratory Science from the University of Cincinnati (2009-2013).
This person is not in any offices
Be The Match BioTherapies
Be The Match BioTherapies® partners with cell and gene therapy companies to save lives through autologous and allogeneic cellular therapy. We are the only cell and gene therapy solutions provider with customizable services to support the entire end-to-end cell therapy supply chain. As part of the National Marrow Donor Program®(NMDP)/Be The Match®, Be The Match BioTherapies has sourced, collected and delivered cells from more than 100,000 volunteer allogeneic donors around the world for time-critical cellular therapies. We have extensive experience providing cellular source material consented for research, clinical and commercial use. Throughout the past 35+ years, Be The Match BioTherapies has developed and continually enhanced their cell collection network and proven cell therapy supply chain infrastructure. The teams are responsible for more than 6,500 time-sensitive cell therapy shipments per year. Through the CIBMTR® (Center for International Blood and Marrow Transplant Research®), Be The Match BioTherapies provides long-term follow-up tracking for the first two FDA-approved CAR-T therapies. We ask that you please review and follow our Community Guidelines to ensure responsible and respectful conversations: http://bit.ly/2Apu7Ja